 | Up a level |
2022
Jobanputra, Vaidehi, Wrzeszczynski, Kazimierz O., Buttner, Reinhard, Caldas, Carlos 
ORCID: 0000-0003-3547-1489, Cuppen, Edwin, Grimmond, Sean ORCID: 0000-0002-8102-7998, Haferlach, Torsten, Mullighan, Charles ORCID: 0000-0002-1871-1850, Schuh, Anna and Elemento, Olivier
(2022).
Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology.
Semin. Cancer Biol., 84.
S. 23 - 32.
LONDON:
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
ISSN 1096-3650
Meggendorfer, Manja, Jobanputra, Vaidehi, Wrzeszczynski, Kazimierz O., Roepman, Paul, de Bruijn, Ewart, Cuppen, Edwin, Buttner, Reinhard, Caldas, Carlos ORCID: 0000-0003-3547-1489, Grimmond, Sean ORCID: 0000-0002-8102-7998, Mullighan, Charles G., Elemento, Olivier, Rosenquist, Richard ORCID: 0000-0002-0211-8788, Schuh, Anna and Haferlach, Torsten
(2022).
Analytical demands to use whole-genome sequencing in precision oncology.
Semin. Cancer Biol., 84.
S. 16 - 23.
LONDON:
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
ISSN 1096-3650
Rosenquist, Richard ORCID: 0000-0002-0211-8788, Cuppen, Edwin, Buettner, Reinhard, Caldas, Carlos ORCID: 0000-0003-3547-1489, Dreau, Helene, Elemento, Olivier, Frederix, Geert, Grimmond, Sean ORCID: 0000-0002-8102-7998, Haferlach, Torsten, Jobanputra, Vaidehi, Meggendorfer, Manja, Mullighan, Charles G., Wordsworth, Sarah and Schuh, Anna
(2022).
Clinical utility of whole-genome sequencing in precision oncology.
Semin. Cancer Biol., 84.
S. 32 - 40.
LONDON:
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD.
ISSN 1096-3650
2020
Blakemore, Stuart J., Clifford, Ruth, Parker, Helen, Antoniou, Pavlos, Stec-Dziedzic, Ewa, Larrayoz, Marta ORCID: 0000-0001-6097-8244, Davis, Zadie, Kadalyayil, Latha, Colins, Andrew, Robbe, Pauline, Vavoulis, Dimitris, Forster, Jade, Carr, Louise, Morilla, Ricardo, Else, Monica, Bryant, Dean, McCarthy, Helen, Walewska, Renata J., Steele, Andrew J., Chan, Jacqueline, Speight, Graham, Stankovic, Tanja, Cragg, Mark S., Catovsky, Daniel, Oscier, David G., Rose-Zerilli, Matthew J. J., Schuh, Anna and Strefford, Jonathan C.
(2020).
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Leukemia, 34 (7).
S. 1760 - 1775.
LONDON:
SPRINGERNATURE.
ISSN 1476-5551
Rhodes, Joanna, Sail, Kavita, Yazdy, Maryam, Hill, Brian, Shadman, Mazyar, Tuncer, Hande H., Winter, Allison, Kennard, Kaitlin, Allan, John, Ujjani, Chaitra, Brander, Danielle, Cho, Sang Kyu, Sharmokh, Simon, Jiang, Dingfeng, Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer, Fox, Christopher, Schuh, Anna, Eyre, Toby, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Wierda, William, Skarbnik, Alan, Roeker, Lindsey, Bannerji, Rajat, Evens, Andrew M., Pauff, James M., Schuster, Steven, Follows, George, Cheson, Bruce D., Eichhorst, Barbara and Mato, Anthony
(2020).
Factors impacting treatment selection in treatment-naive patients with CLL: a multicenter study.
Leuk. Lymphoma, 61.
S. 104 - 106.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Rose-Zerilli, Matthew, Wojdacz, Tomasz, Amarasinghe, Harindra, Kadalayil, Latha, Blakemore, Stuart, Parker, Helen, Bryant, Dean, Larrayoz, Marta, Clifford, Ruth, Robbe, Pauline, Davis, Zadie, Else, Monica, Howard, Dena, Steele, Andrew, Brandell, Richard Rosenquist, Collins, Andrew, Pettitt, Andrew, Hillmen, Peter, Plass, Christoph, Schuh, Anna, Catovsky, Daniel, Oscier, David, Oakes, Christopher and Strefford, Jonathan (2020). Clinico-biological significance of DNA methylation in chronic lymphocytic leukaemia patients: results from three UK clinical trials. Leuk. Lymphoma, 61. S. 100 - 103. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
2019
Wojdacz, Tomasz K., Amarasinghe, Harindra E., Kadalayil, Latha, Beattie, Alice, Forster, Jade, Blakemore, Stuart J., Parker, Helen, Bryant, Dean, Larrayoz, Marta, Clifford, Ruth, Robbe, Pauline, Davis, Zadie A., Else, Monica, Howard, Dena R., Stamatopoulos, Basile, Steele, Andrew J., Rosenquist, Richard, Collins, Andrew ORCID: 0000-0001-7108-0771, Pettitt, Andrew R., Hillmen, Peter, Plass, Christoph, Schuh, Anna, Catovsky, Daniel, Oscier, David G., Rose-Zerilli, Matthew J. J., Oakes, Christopher C. and Strefford, Jonathan C.
(2019).
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Blood Adv., 3 (16).
S. 2474 - 2482.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 2473-9537
2018
Mato, Anthony R., Yazdy, Maryam Sarraf, Hill, Brian T., Shadman, Mazyar, Tuncer, Hande, Winter, Allison M., Kennard, Kaitlin, Allan, John N., Ujjani, Chaitra S., Brander, Danielle M., Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer R., Fox, Christopher P., Rhodes, Joanna, Schuh, Anna, Eyre, Toby A., Lamanna, Nicole, Jain, Nitin, Wierda, William G., Skarbnik, Alan P., Roeker, Lindsey E., Bannerji, Rajat, Evens, Andrew M., Lansigan, Frederick, Samp, Jennifer C., Nielsen, Jacqueline, Pauff, James M., Kipps, Thomas J., Schuster, Stephen J., Follows, George A., Cheson, Bruce and Eichhorst, Barbara
(2018).
Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study.
Blood, 132.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Hillmen, Peter, Seymour, John F., Coutre, Steven, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Mulligan, Stephen P., Schuh, Anna, Assouline, Sarit, Wendtner, Clemens-Martin, Roberts, Andrew W., Davids, Matthew S., Bloehdorn, Johannes, Munir, Talha, Boettcher, Sebastian, Zhou, Lang, Salem, Ahmed Hamed, Desai, Monali, Chyla, Brenda, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Gordon, Gary, Hallek, Michael and Wierda, William G.
(2018).
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.
J. Clin. Oncol., 36 (19).
S. 1973 - 1984.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Eradat, Herbert Aaron, Robak, Tadeusz, Delgado, Julio ORCID: 0000-0002-5157-4376, Schuh, Anna, Pristupa, Alexander S., Omyla-Staszewska, Joanna, Barrlentos, Jacqueline Claudia, Farber, Charles Michael, MacDonald, Donald, Jacob, Abraham, Sharman, Jeff Porter, Loscertales, Javier, Brown, Jennifer R., Colffier, Bertrand, Ghia, Paolo, Zelenetz, Andrew David, Evans, Shelley, Jahn, Thomas Michael, Hallek, Michael J. and Hillmen, Peter
(2014).
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efFicacy and safely or idelalisib (GS-1101) in combination with bendamustine and Minimal) for previously treated chronic lymphocytic leukemia (CLL).
J. Clin. Oncol., 32 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755